Skip to search formSkip to main contentSkip to account menu

L 105 (rifaximin)

Known as: L 105, L-105 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
15. Oomori, Y.,Ogawa, M.,Miyazaki, S.,Goto, S.: Fundamentalstudies on experimental urinary tract infection with various species… 
1988
1988
Cefuzonam (CZON, L-105) was used clinically for the treatment of obstetrical and gynecological infections at a dosage of 1 g once… 
1988
1988
Cefuzonam (L-105, CZON), a new beta-lactam antibiotic, was studied for its transfer into intrapelvic tissues and for clinical… 
1987
1987
Fundamental and clinical studies on cefuzonam (L-105, CZON), a newly semisynthesized cephem antibiotic, were carried out in the… 
1987
1987
Cefuzonam (L-105, CZON) was studied in pediatric infections. A summary of the results it as follows: For recently isolated… 
1987
1987
Cefuzoname (CZON, L-105) a newly developed cephalosporin, has broad spectrum on Gram-positive or -negative bacteria and may also… 
1987
1987
To evaluate the usefulness and the safety of cefuzonam (CZON, L-105) against obstetric and gynecological infections, we conducted… 
1987
1987
Pharmacokinetic and clinical studies were conducted to evaluate cefuzonam (L-105, CZON), a new cephem type antibiotic, in the… 
1987
1987
A new cephem antibiotic, cefuzonam (L-105, CZON) was studied for its concentrations in serum and clinical efficacy in the field… 
1987
1987
Cefuzonam (CZON, L-105), a cephem type antibiotic, was clinically studied in the field of obstetrics and gynecology. The results…